STOCK TITAN

Numinus to Host Q1 2023 Results Conference Call on January 16, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Numinus Wellness Inc. (TSX: NUMI, OTCQX: NUMIF), a pioneer in mental health care and psychedelic-assisted therapies, will announce its financial results for Q1 2023, ending November 30, 2022, on January 16, 2023. The results will be disclosed after market close, followed by a conference call and webcast at 5:30 p.m. Eastern time. Participants can register for the live event and access a replay after the call. Numinus focuses on innovative treatments for mental health issues, aiming to integrate these therapies into mainstream practice.

Positive
  • None.
Negative
  • None.

VANCOUVER, BC, Jan. 4, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results for the quarter ended November 30, 2022, after market close on Monday, January 16, 2023.

Interested parties are invited to participate in the Company's Q1 2023 results conference call and webcast occurring on the same day, at 5:30 p.m. Eastern time / 2:30 p.m. Pacific time. During the call, Numinus executives will review the Company's performance and recent initiatives, and answer questions from analysts.

To listen to the live webcast, please register at:
https://events.q4inc.com/attendee/823058344 

The webcast will also be archived on the Events and Presentations page of Numinus' Investor Relations website: https://www.investors.numinus.com/events-and-presentations

To participate in the live conference call, please use the following dial-in information:

  • 1 (888) 330-3632 (Toll-free North America)
  • 1 (646) 960-0837 (International)
  • Please ask to participate in Numinus' Q1 2023 Results Call. To avoid any delays in joining the call, please dial in at least five minutes prior to the call start time. If prompted, please provide conference passcode 3547386.

A replay of the conference call can also be accessed after 8:30 p.m. Eastern time / 5:30 p.m. Pacific time on January 16, 2023, at 1-800-770-2030 or 1-647-362-9199 (using passcode 3547386). The replay will be available until January 30, 2023.

About Numinus
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society. 

Learn more at numinus.com and follow us on LinkedInFacebookTwitter, and Instagram.

Forward-Looking Statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Cision View original content:https://www.prnewswire.com/news-releases/numinus-to-host-q1-2023-results-conference-call-on-january-16-2023-301712860.html

SOURCE Numinus Wellness Inc.

FAQ

When will Numinus Wellness release its Q1 2023 financial results?

Numinus Wellness will release its financial results for the quarter ended November 30, 2022, on January 16, 2023, after market close.

What time is the Numinus Wellness Q1 2023 results conference call?

The conference call for Numinus Wellness Q1 2023 results will take place at 5:30 p.m. Eastern time on January 16, 2023.

How can I access the Numinus Wellness Q1 2023 results webcast?

You can access the Numinus Wellness Q1 2023 results webcast by registering at their designated registration link prior to the event.

Is there a replay available for the Numinus Wellness Q1 2023 results call?

Yes, a replay of the Numinus Wellness Q1 2023 results conference call will be available after 8:30 p.m. Eastern time on January 16, 2023.

What is Numinus Wellness's focus in mental health care?

Numinus Wellness focuses on innovative treatments and safe, evidence-based psychedelic-assisted therapies for mental health issues.

NUMINUS WELLNESS INC

OTC:NUMIF

NUMIF Rankings

NUMIF Latest News

NUMIF Stock Data

10.90M
309.90M
3.85%
2.67%
Medical Care Facilities
Healthcare
Link
United States of America
Vancouver